Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Thomas Felix, John B. Jordan, Catherine Akers, Bina Patel & Daniela Drago. (2019) Current state of biologic pharmacovigilance in the European Union: improvements are needed. Expert Opinion on Drug Safety 18:3, pages 231-240.
Read now
Read now
Ashraf Mikhail & Christopher Brown. (2015) Clinical efficacy and safety of biosimilar epoetin: focus on epoetin zeta. Biosimilars 5, pages 65-73.
Read now
Read now
Mary Lynn Davis-Ajami, Jun Wu, Katherine Downton, Emilie Ludeman & Virginia Noxon. (2014) Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility. Biologics: Targets and Therapy 8, pages 155-167.
Read now
Read now
Wolfgang Jelkmann. (2012) Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatments. Expert Opinion on Biological Therapy 12:5, pages 581-592.
Read now
Read now
Andreas Nechansky & Ralf Kircheis. (2010) Immunogenicity of therapeutics: a matter of efficacy and safety. Expert Opinion on Drug Discovery 5:11, pages 1067-1079.
Read now
Read now
Articles from other publishers (31)
Mark A. Kroenke, Mark N. Milton, Seema Kumar, Eris Bame & Joleen T. White. (2021) Immunogenicity Risk Assessment for Multi-specific Therapeutics. The AAPS Journal 23:6.
Crossref
Crossref
A. Peter Hall, Jeffrey S. Tepper, Molly H. Boyle, Maurice G. Cary, Thierry G. Flandre, Alessandro Piaia, Inge Tarnow, Nicholas P. Macri, Mark C. Freke, Kristen J. Nikula, Graham R. Paul, Annick Cauvin, Michela Gregori, Richard Haworth, Stuart Naylor, Mark Price, Ian N. Robinson, Andrew Allen, Tom Gelzleichter, Andreas M. Hohlbaum, Scott Manetz, Alison Wolfreys, Karyn Colman, Renaud Fleurance, David Jones & Sydney Mukaratirwa. (2021) BSTP Review of 12 Case Studies Discussing the Challenges, Pathology, Immunogenicity, and Mechanisms of Inhaled Biologics. Toxicologic Pathology 49:2, pages 235-260.
Crossref
Crossref
Obinna C. Ubah, Andrew J. Porter & Caroline J. Barelle. (2020)
In Vitro
ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA: An Encouraging Milestone to Further Clinical Drug Development
. Journal of Immunology Research 2020, pages 1-14.
Crossref
Crossref
Lissy de Ridder, Amit Assa, Jiri Bronsky, Claudio Romano, Richard K. Russell, Nadeem A. Afzal, Almuthe C. Hauer, Daniela Knafelz, Paolo Lionetti, Caterina Strisciuglio, Gábor Veres, Harland Winter, Victorien M. Wolters, Malgorzata Sladek, Arnold G. Vulto & Jorge A. Dias. (2019) Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN. Journal of Pediatric Gastroenterology & Nutrition 68:1, pages 144-153.
Crossref
Crossref
M. Reza Nejadnik, Theodore W. Randolph, David B. Volkin, Christian Schöneich, John F. Carpenter, Daan J.A. Crommelin & Wim Jiskoot. (2018) Postproduction Handling and Administration of Protein Pharmaceuticals and Potential Instability Issues. Journal of Pharmaceutical Sciences 107:8, pages 2013-2019.
Crossref
Crossref
Austin L. Daniels & Theodore W. Randolph. (2018) Flow Microscopy Imaging Is Sensitive to Characteristics of Subvisible Particles in Peginesatide Formulations Associated With Severe Adverse Reactions. Journal of Pharmaceutical Sciences 107:5, pages 1313-1321.
Crossref
Crossref
Antonello Di Paolo & Elena Arrigoni. (2018) Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges. Drugs 78:4, pages 399-410.
Crossref
Crossref
Sahar Awwad, Athmar Al-Shohani, Peng T. Khaw & Steve Brocchini. (2018) Comparative Study of In Situ Loaded Antibody and PEG-Fab NIPAAM Gels. Macromolecular Bioscience 18:2, pages 1700255.
Crossref
Crossref
Joerg Schmohl, Deborah Todhunter, Elizabeth Taras, Veronika Bachanova & Daniel Vallera. (2018) Development of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell Malignancies. Toxins 10:1, pages 32.
Crossref
Crossref
Sahar Awwad, Abeer H A Mohamed Ahmed, Garima Sharma, Jacob S Heng, Peng T Khaw, Steve Brocchini & Alastair Lockwood. (2017) Principles of pharmacology in the eye. British Journal of Pharmacology 174:23, pages 4205-4223.
Crossref
Crossref
Jennifer H. Grossman, Rachael M. Crist & Jeffrey D. Clogston. (2016) Early Development Challenges for Drug Products Containing Nanomaterials. The AAPS Journal 19:1, pages 92-102.
Crossref
Crossref
Alison Smith, Hugh Manoli, Stacey Jaw, Kimberley Frutoz, Alan L. Epstein, Leslie A. Khawli & Frank-Peter Theil. (2016) Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins. Journal of Immunology Research 2016, pages 1-9.
Crossref
Crossref
Sarfaraz Niazi. 2015. Biosimilars and Interchangeable Biologics. Biosimilars and Interchangeable Biologics
81
134
.
Sarfaraz Niazi. 2015. Biosimilars and Interchangeable Biologics. Biosimilars and Interchangeable Biologics
83
122
.
Sarfaraz Niazi. 2015. Biosimilars and Interchangeable Biologics. Biosimilars and Interchangeable Biologics
1
22
.
Marina A. Dobrovolskaia. (2015) Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy. Journal of Controlled Release 220, pages 571-583.
Crossref
Crossref
Joerg U. Schmohl, Deborah Todhunter, Seung Oh & Daniel A. Vallera. (2015) Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development. Toxins 7:10, pages 4067-4082.
Crossref
Crossref
Sahar Awwad, Alastair Lockwood, Steve Brocchini & Peng T. Khaw. (2015) The PK-Eye: A Novel In Vitro Ocular Flow Model for Use in Preclinical Drug Development. Journal of Pharmaceutical Sciences 104:10, pages 3330-3342.
Crossref
Crossref
Angelika J. Freitag, Maliheh Shomali, Stylianos Michalakis, Martin Biel, Michael Siedler, Zehra Kaymakcalan, John F. Carpenter, Theodore W. Randolph, Gerhard Winter & Julia Engert. (2014) Investigation of the Immunogenicity of Different Types of Aggregates of a Murine Monoclonal Antibody in Mice. Pharmaceutical Research 32:2, pages 430-444.
Crossref
Crossref
Natasha Irrera, Alessandra Bitto, Gabriele Pizzino, Mario Vaccaro, Francesco Squadrito, Mariarosaria Galeano, Francesco Stagno d’Alcontres, Ferdinando Stagno d’Alcontres, Michele Buemi, Letteria Minutoli, Michele Rosario Colonna & Domenica Altavilla. (2015) Epoetin Alpha and Epoetin Zeta: A Comparative Study on Stimulation of Angiogenesis and Wound Repair in an Experimental Model of Burn Injury. BioMed Research International 2015, pages 1-9.
Crossref
Crossref
Sarfaraz K. Niazi. 2014. Handbook of Bioequivalence Testing. Handbook of Bioequivalence Testing
756
787
.
Dujon R.W. Fuzzard, Heather G. Mack & R.C. Andrew Symons. (2014) Bilateral Retrobulbar Optic Neuropathy in the Setting of Interferon Alpha-2a Therapy. Case Reports in Ophthalmology 5:2, pages 270-276.
Crossref
Crossref
S.R. Lentz, S. Ehrenforth, F. Abdul Karim, T. Matsushita, K.N. Weldingh, J. Windyga & J.N. Mahlangu. (2014) Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa. Journal of Thrombosis and Haemostasis 12:8, pages 1244-1253.
Crossref
Crossref
Zohreh Tatari-Calderone, Naomi L.C. Luban & Stanislav Vukmanovic. (2014) Genetics of Transfusion Recipient Alloimmunization: Can Clues from Susceptibility to Autoimmunity Pave the Way?. Transfusion Medicine and Hemotherapy 41:6, pages 436-445.
Crossref
Crossref
Theresa Reynolds, Christina de Zafra, Amy Kim & Thomas R. Gelzleichter. 2013. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics
3
33
.
Klaus Bendtzen. (2012) Anti-TNF-α biotherapies: perspectives for evidence-based personalized medicine. Immunotherapy 4:11, pages 1167-1179.
Crossref
Crossref
Jae Kuk Ryu, Hyo Sun Kim & Doo Hyun Nam. (2012) Current status and perspectives of biopharmaceutical drugs. Biotechnology and Bioprocess Engineering 17:5, pages 900-911.
Crossref
Crossref
Adda Grimberg, Chris Feudtner & Catherine M. Gordon. (2012) Consequences of Brand Switches During the Course of Pediatric Growth Hormone Treatment. Endocrine Practice 18:3, pages 307-316.
Crossref
Crossref
J?rgen Dahlstr?m & Lennart Venemalm. 2011. Detection and Quantification of Antibodies to Biopharmaceuticals. Detection and Quantification of Antibodies to Biopharmaceuticals
211
231
.
Robert J. Falconer, Dianne Jackson-Matthews & Stephen M. Mahler. (2011) Analytical strategies for assessing comparability of biosimilars. Journal of Chemical Technology & Biotechnology 86:7, pages 915-922.
Crossref
Crossref
Joydeep Basu, Christopher W Genheimer, Namrata Sangha, Sarah F Quinlan, Kelly I Guthrie, Rusty Kelley, Roger M Ilagan, Deepak Jain, Timothy Bertram & John W Ludlow. (2011) Organ specific regenerative markers in peri-organ adipose: kidney. Lipids in Health and Disease 10:1, pages 171.
Crossref
Crossref